DrugPatentWatch Database Preview
Drugs in Development Information for Trafermin
Drug Development Status for Trafermin: Sponsors, patents, clinical trial progress
Trafermin is an investigational drug.
There have been 6 clinical trials for Trafermin.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2010.
The most common disease conditions in clinical trials are Periodontitis, Ulcer, and Foot Ulcer. The leading clinical trial sponsors are Kaken Pharmaceutical, Olympus Biotech Corporation, and [disabled in preview].
There are four US patents protecting this investigational drug and twenty-six international patents.
Summary for Trafermin
| US Patents | 4 |
| International Patents | 26 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2010-12-01) |
| Vendors | 0 |
Recent Clinical Trials for Trafermin
| Title | Sponsor | Phase |
|---|---|---|
| The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study | Olympus Biotech Corporation | Phase 3 |
| The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study | Olympus Biotech Corporation | Phase 3 |
| A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3) | Kaken Pharmaceutical | Phase 3 |
Clinical Trial Summary for Trafermin
Top disease conditions for Trafermin
Top clinical trial sponsors for Trafermin
US Patents for Trafermin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Trafermin | Start Trial | Agent for regenerating tympanic membrane or external auditory canal | NOBELPHARMA CO., LTD. (Tokyo, JP) | Start Trial |
| Trafermin | Start Trial | Polysaccharides for pulmonary delivery of active agents | Momenta Pharmaceuticals, Inc. (Cambridge, MA) | Start Trial |
| Trafermin | Start Trial | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | Torrent Pharmaceuticals Limited (Ahmedabad, IN) | Start Trial |
| Trafermin | Start Trial | Modified release composition for highly soluble drugs | Torrent Pharmaceuticals Limited (Ahmedabad, IN) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Trafermin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Trafermin | Australia | 2009263249 | 2028-06-26 | Start Trial |
| Trafermin | Brazil | PI0915387 | 2028-06-26 | Start Trial |
| Trafermin | Canada | 2729093 | 2028-06-26 | Start Trial |
| Trafermin | China | 102131478 | 2028-06-26 | Start Trial |
| Trafermin | China | 105381506 | 2028-06-26 | Start Trial |
| Trafermin | European Patent Office | 2353547 | 2028-06-26 | Start Trial |
| Trafermin | Spain | 2671068 | 2028-06-26 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
